Episode 60
Episode 59. Management of Systemic Mastocytosis with Dr. Daniel DeAngelo
Blood Cancer Talks · Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
May 8, 20251h 3m
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, we discussed the management of systemic mastocytosis with Dr. Daniel DeAngelo from the Dana Farber Cancer Institute. Here are the key studies we discussed:
- Midostaurin https://www.nejm.org/doi/10.1056/NEJMoa1513098?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov
- Avapritinib
- EXLPORER study: https://www.nature.com/articles/s41591-021-01538-9
- PATHFINDER study: https://www.nature.com/articles/s41591-021-01539-8
- Bezuclastinib: APEX trial: https://ashpublications.org/blood/article/144/Supplement%201/659/530240/Apex-Part-1-Updated-Assessment-of-Bezuclastinib
- HSCT for Advanced SM: https://ascopubs.org/doi/10.1200/JCO.2014.55.2018
Topics
HematologyCancer